Oral Delivery of Psoralidin by Mucoadhesive Surface-Modified Bilosomes Showed Boosted Apoptotic and Necrotic Effects against Breast and Lung Cancer Cells

Keyphrases

• Breast Cancer Cells 100%
• Chitosan 100%
• Bilosomes 100%
• Lung Cancer Cells 100%
• Mucoadhesive 100%
• Psoralidin 100%
• Entrapment Efficiency 100%
• Oral Bioavailability 100%
• Oral Delivery 100%
• Agglomeration 50%
• Breast Cancer 50%
• Oral Use 50%
• Higuchi Model 50%
• Necrotic Cells 50%
• Thin Film Hydration 50%
• Cholesterol 50%
• Human Lung Adenocarcinoma Cells 50%
• High zeta Potential 50%
• Physicochemical Properties 50%
• Zeta Potential 50%
• MCF-7 Cancer Cell Line 50%
• Nanoformulation 50%
• Particle Size 50%
• Lung Cancer 50%
• Molar Ratio 50%
• Span 60 50%
• Residence Time 50%
• Sustained Release Behavior 50%
• Formulation Optimization 50%
• Spherical Shape 50%
• Chitosan-coated 50%
• Sodium Deoxycholate 50%
• Efficiency Potential 50%
• Oral Administration 50%
• Gastrointestinal Tract 50%
• Phosphatidylcholine 50%
• Apoptotic Cells 50%
• Diffusion Model 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Breast Cancer 100%
• Lung Cancer 100%
• Chitosan 100%
• Zeta Potential 66%
• Bioavailability 66%
• Egg Lecithin 33%
• Sorbitan Monostearate 33%
• Lung Adenocarcinoma 33%
• Hydration 33%
• Deoxycholate Sodium 33%
• Sustained Release 33%